Concepedia

Inge Lefevre

IL

20

Publications

1.5K

Citations

15

H-Index

2005

Active since

Affiliations

Takeda (Switzerland)(Current)

Takeda (United States)

Research Institute for Tropical Medicine

Universidad Nacional Autónoma de Nicaragua-León

Secretaría Nacional de Ciencia, Tecnología e Innovación

Inge Lefevre is an author at Takeda (Switzerland) specializing in vaccination, medicine, and vaccine development.

Top concepts

Publications per year

2005–2024

20

Publications

20

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

Shibadas Biswal, Humberto Reynales, Xavier Sáez‐Llorens et al. · New England Journal of Medicine · 2019 · 357 citations · Full text

Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

Shibadas Biswal, Charissa Borja-Tabora, Luis Martinez Vargas et al. · The Lancet · 2020 · 237 citations

, , +5

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)

Luis Rivera, Shibadas Biswal, Xavier Sáez‐Llorens et al. · Clinical Infectious Diseases · 2021 · 226 citations · Full text

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

Vianney Tricou, Delia Yu, Humberto Reynales et al. · The Lancet Global Health · 2024 · 189 citations · Full text

Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial

Vianney Tricou, Xavier Sáez‐Llorens, Delia Yu et al. · The Lancet · 2020 · 103 citations

, , +6

Rows per page

1–5 of 20